ApprovalTrail

Approval · Notice of Compliance 2423 · 2001

METADOL: Notice of Compliance 2423

Issued July 30, 2001

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2423
Date
July 30, 2001
Company
Pharmascience Inc.Montreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Removal of the indication treatment of opioid dependence
Therapeutic class
Opioid analgesic

Products in this notice

BrandDINStatus today
METADOLNot yet assigned—

Medicinal ingredients